Article
Using germline genotype in cancer pharmacogenetic studies.
Pharmacogenomics - 1 Mar 2009
McWhinney Sarah R, McLeod Howard L
Abstract excerpt
Pharmacogenetics provides great opportunity for improving both the chance of therapeutic benefit and the ability to avoid adverse drug events. To date, the majority of pharmacogenetic studies have been performed using germline DNA. DNA collection in most clinical trials provides a wealth of samples from which pharmacogenetic studies can be launched. However, there is concern that the data from germline DNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.